RAC 0.00% $1.66 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-15

  1. 923 Posts.
    lightbulb Created with Sketch. 230
    yep, since when did we not have the patent on bisantrene!
    there’s been a few cases of these explanations supporting rc220 that have made we question what I was invested in last few years, esp in reference to rc110 being basically unusable except in aml, so cpacs and FTO without rc220 was basically a fairytale.


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.